About CardiacSense
CardiacSense is a company based in Caesarea (Israel) founded in 2012. CardiacSense has raised $10 million across 5 funding rounds from investors including European Union and EIC Fund. CardiacSense operates in a competitive market with competitors including Withings, Ultrahuman, iRhythm Tech, AliveCor and iHealth Labs, among others.
- Headquarter Caesarea, Israel
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 5 rounds
-
Latest Funding Round
$6 M (USD), Series B
Jun 16, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CardiacSense
Unlock access to complete
Unlock access to complete
Funding Insights of CardiacSense
CardiacSense has successfully raised a total of $10M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CardiacSense
CardiacSense has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CardiacSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CardiacSense
Investment portfolio details for CardiacSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CardiacSense
Detailed financials for CardiacSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardiacsense Comparisons
Peer comparison for CardiacSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CardiacSense
CardiacSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, iRhythm Tech, AliveCor and iHealth Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
Detailed competitors of CardiacSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardiacsense
Complete news archive for CardiacSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardiacSense
CardiacSense was founded in 2012 and raised its 1st funding round 6 years after it was founded.
CardiacSense is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
CardiacSense is a funded company, having raised a total of $10M across 5 funding rounds to date.
CardiacSense was founded in 2012 in Caesarea, Israel, within the medical technology sector. Non-invasive wrist-worn sensors are developed by the company to enable continuous monitoring and diagnosis of cardiac conditions, including arrhythmia, cardiac arrest, and atrial fibrillation, along with vital signs. Operations focus on healthcare applications for patient surveillance in clinical and remote settings.
CardiacSense's top competitors include Withings, Ultrahuman and Oura.
CardiacSense has 2 investors. Key investors include European Union, and EIC Fund.
The valuation of CardiacSense is $20.5M as of May 2018.